Re: Korobelnik et al.: Intravitreal aflibercept for diabetic macular edema (Ophthalmology 2014;121:2247-54)

被引:1
|
作者
Hashmonay, Ron [1 ]
Parikh, Soumil [1 ]
机构
[1] Novartis, Basel, Switzerland
关键词
RANIBIZUMAB; RESTORE; LASER;
D O I
10.1016/j.ophtha.2014.09.041
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:E37 / E38
页数:3
相关论文
共 50 条
  • [41] Re: Ikuno et al.: Intravitreal aflibercept injection in patients with myopic choroidal neovascularization: the MYRROR study (Ophthalmology 2015; 122: 1220-7) REPLY
    Ikuno, Yasushi
    Ohno-Matsui, Kyoko
    Wong, Tien Y.
    Korobelnik, Jean-Francois
    Vitti, Robert
    Li, Tummy
    Stemper, Brigitte
    Asmus, Friedrich
    Zeitz, Oliver
    Ishibashi, Tatsuro
    OPHTHALMOLOGY, 2016, 123 (02) : E17 - E18
  • [42] Re: Halford et al.: Detailed phenotypic and genotypic characterization of Bietti crystalline dystrophy (Ophthalmology 2014;121:1174-84) reply
    Halford, Stephanie
    Liew, Gerald
    Mackay, Donna S.
    Sergouniotis, Panagiotis I.
    Holt, Richard
    Broadgate, Suzanne
    Volpi, Emanuela V.
    Ocaka, Louise
    Robson, Anthony G.
    Holder, Graham E.
    Moore, Anthony T.
    Michaelides, Michel
    Webster, Andrew R.
    OPHTHALMOLOGY, 2015, 122 (04) : E22 - E22
  • [43] Re: Yu et al.: Releasable encircling band for primary rhegmatogenous retinal detachment (Ophthalmology 2014;121:2504-5) Reply
    Yu, Xi Ling
    Liang, Xiao Ling
    Ding, Xiao Yan
    Hu, Jie
    Qing, Jia
    Zhu, Xiao Bo
    Huang, Xin Hua
    Stewart, Jay M.
    Li, Yong Hao
    Jonas, Jost B.
    Lu, Lin
    OPHTHALMOLOGY, 2015, 122 (08) : E51 - E52
  • [44] Re: Charlson et al.: Nocturnal systemic hypotension increases the risk of glaucoma progression (Ophthalmology 2014;121:2004-10) Reply
    Charlson, Mary E.
    De Moraes, C. Gustavo
    Liebmann, Jeffrey M.
    Wells, Martin T.
    Link, Alissa
    Harmon, Gregory
    Peterson, Janey C.
    Ritch, Robert
    OPHTHALMOLOGY, 2015, 122 (02) : E15 - E16
  • [45] Re: Coster et al.: A comparison of lamellar and penetrating keratoplasty outcomes: a registry study (Ophthalmology 2014;121:979-87) Reply
    Coster, Douglas J.
    Keane, Miriam C.
    Williams, Keryn A.
    OPHTHALMOLOGY, 2014, 121 (10) : E59 - E60
  • [46] Re: Sundaram et al.: Retinal structure and function in achromatopsia: implications for gene therapy (Ophthalmology 2014;121:234-45) reply
    Sundaram, Venki
    Carroll, Joseph
    Michaelides, Michel
    OPHTHALMOLOGY, 2014, 121 (08) : E41 - E41
  • [47] Re: Charlson et al.: Nocturnal systemic hypotension increases the risk of glaucoma progression (Ophthalmology 2014; 121: 2004-12) Reply
    Charlson, Mary E.
    De Moraes, C. Gustavo
    Liebmann, Jeffrey M.
    Wells, Martin T.
    Link, Alissa
    Harmon, Gregory
    Peterson, Janey C.
    Ritch, Robert
    OPHTHALMOLOGY, 2015, 122 (04) : E26 - E27
  • [48] Re: Lepore et al.: Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings (Ophthalmology 2014;121:2212-9) Reply
    Lepore, Domenico
    Quinn, Graham E.
    OPHTHALMOLOGY, 2015, 122 (08) : E49 - E50
  • [49] Re: Shah et al.: The state of ophthalmology medical student education in the United States and Canada, 2012 through 2013 (Ophthalmology 2014;121:1160-3) Reply
    Bakri, Sophie J.
    Moshfeghi, Darius M.
    Francom, Steve
    Rundle, Amy Chen
    Reshef, Daniel S.
    Lee, Paul P.
    Schaeffer, Carol
    Rubio, Roman G.
    Lai, Phillip
    OPHTHALMOLOGY, 2015, 122 (03)
  • [50] Re: Zur et al.: OCT biomarkers as functional outcome predictors in diabetic macular edema treated with dexamethasone implant (Ophthalmology. 2018;125:267-275) Reply
    Zur, Dinah
    Iglicki, Matias
    Busch, Catharina
    Lupidi, Marco
    Loewenstein, Anat
    OPHTHALMOLOGY, 2018, 125 (09) : E61 - E62